FR2874009B1 - Utilisation d'alcoxybenzenes comme agent stimulateur sanguin - Google Patents

Utilisation d'alcoxybenzenes comme agent stimulateur sanguin

Info

Publication number
FR2874009B1
FR2874009B1 FR0408725A FR0408725A FR2874009B1 FR 2874009 B1 FR2874009 B1 FR 2874009B1 FR 0408725 A FR0408725 A FR 0408725A FR 0408725 A FR0408725 A FR 0408725A FR 2874009 B1 FR2874009 B1 FR 2874009B1
Authority
FR
France
Prior art keywords
alcoxybenzenes
stimulating agent
blood stimulating
blood
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0408725A
Other languages
English (en)
Other versions
FR2874009A1 (fr
Inventor
Jonathan Warr
Satomi Kunieda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takasago International Corp
Original Assignee
Takasago International Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takasago International Corp filed Critical Takasago International Corp
Priority to FR0408725A priority Critical patent/FR2874009B1/fr
Priority to EP05291599A priority patent/EP1661561A1/fr
Priority to JP2005228434A priority patent/JP2006045236A/ja
Priority to US11/198,348 priority patent/US20060035982A1/en
Publication of FR2874009A1 publication Critical patent/FR2874009A1/fr
Application granted granted Critical
Publication of FR2874009B1 publication Critical patent/FR2874009B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/10—Polyhydroxy benzenes; Alkylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/205—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring
    • C07C43/2055—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring the aromatic ring being a non-condensed ring containing more than one ether bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
FR0408725A 2004-08-06 2004-08-06 Utilisation d'alcoxybenzenes comme agent stimulateur sanguin Expired - Fee Related FR2874009B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0408725A FR2874009B1 (fr) 2004-08-06 2004-08-06 Utilisation d'alcoxybenzenes comme agent stimulateur sanguin
EP05291599A EP1661561A1 (fr) 2004-08-06 2005-07-27 Compositions cosmétiques et dermatologiques pour le traitement de la peau et du cuir chevelu
JP2005228434A JP2006045236A (ja) 2004-08-06 2005-08-05 血行促進剤
US11/198,348 US20060035982A1 (en) 2004-08-06 2005-08-08 Method for promoting blood stream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0408725A FR2874009B1 (fr) 2004-08-06 2004-08-06 Utilisation d'alcoxybenzenes comme agent stimulateur sanguin

Publications (2)

Publication Number Publication Date
FR2874009A1 FR2874009A1 (fr) 2006-02-10
FR2874009B1 true FR2874009B1 (fr) 2006-12-01

Family

ID=34947047

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0408725A Expired - Fee Related FR2874009B1 (fr) 2004-08-06 2004-08-06 Utilisation d'alcoxybenzenes comme agent stimulateur sanguin

Country Status (4)

Country Link
US (1) US20060035982A1 (fr)
EP (1) EP1661561A1 (fr)
JP (1) JP2006045236A (fr)
FR (1) FR2874009B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010143884A (ja) * 2008-12-22 2010-07-01 Shiseido Co Ltd 肌荒れ改善剤
CN102557894B (zh) * 2012-01-13 2014-05-14 浙江优创材料科技股份有限公司 一种1,2,3—三甲氧基苯的合成工艺

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB897743A (en) * 1958-07-10 1962-05-30 Louis Lafon Improvements in or relating to pharmaceutical compositions containing polyglycol
US3093544A (en) * 1959-12-30 1963-06-11 Lafon Louis Method of relieving pain employing 1, 3, 5-trihydroxy-benzene
GB1000783A (en) * 1962-04-12 1965-08-11 Orsymonde Improvements in or relating to pharmaceutical compositions containing polyhydroxybenzene derivatives
JP3519747B2 (ja) * 1992-09-25 2004-04-19 高砂香料工業株式会社 鎮静効果を与える香料改質剤
FR2772613B1 (fr) * 1997-12-19 2003-05-09 Oreal Utilisation du phloroglucinol dans une composition cosmetique
JP3590274B2 (ja) * 1998-09-11 2004-11-17 株式会社資生堂 気化吸引用鎮静剤及びそれを有効成分とする鎮静香料組成物
US6315980B1 (en) * 1998-09-25 2001-11-13 Shiseido Company, Ltd. Skin barrier function recovery and promotion composition and evaluation method thereof
JP2001316317A (ja) * 2000-05-01 2001-11-13 Kao Corp 血行促進剤

Also Published As

Publication number Publication date
JP2006045236A (ja) 2006-02-16
EP1661561A1 (fr) 2006-05-31
FR2874009A1 (fr) 2006-02-10
US20060035982A1 (en) 2006-02-16

Similar Documents

Publication Publication Date Title
LTPA2017004I1 (lt) Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės-delta inhibitoriai
CY2016035I1 (el) Θεραπευτικη χρηση αντισωματων anti-cs1
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
FR12C0019I2 (fr) O-cyclopropyle-carboxanilides et leur utilisation comme fongicides
DK2298237T3 (da) Hjerteprotese
DE502004010419D1 (de) Retraktor zur durchführung von herz- und thoraxchirurgischen eingriffen
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
FR2852392B1 (fr) Composition de fixation tissulaire
EP1708757A4 (fr) Utilisation de cellules souches pluripotentes derivees de sang ombilical humain pour le traitement de maladies
FR2875398B1 (fr) Implant articulaire d'interposition
DE602004004262D1 (de) Ultraschallbehandlung von gewebematrices
FR2874009B1 (fr) Utilisation d'alcoxybenzenes comme agent stimulateur sanguin
DE602004013599D1 (de) Herstellung von somatostatinpeptiden
FR2866562B1 (fr) Utilisation d'un tetrapolymere acrylique comme agent tenseur de la peau.
DK1461042T3 (da) Anvendelse af desoxypeganin til behandling af klinisk depression
FR2850578B1 (fr) Utilisation de n-arylmethylene ethylenediaminetriacetates, n-arylmethyleneiminodiacetates ou n,n'-diarylmethylene ethylenediamineacetates comme donneurs de no
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv
FR2875127B1 (fr) Prothese de poignet
FR2849595B1 (fr) Utilisation du bocoa prouacensis comme agent amincissant
FR2899474B1 (fr) Utilisation de compose c-glycoside derive d- et l-fucose comme agent activateur et regulateur de l'imminite cutanee
FR2908650B1 (fr) Utilisation d'une alkyloxazolidinone comme agent cosmetique hydratant et procede d'hydratation de la peau.
FR2883172B1 (fr) Utilisation d'un tensioactif gemine comme agent anti-rides
SE0303588D0 (sv) Surface protection of exposed biological tissues

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120430